 MENLO PARK, Calif.--BUSINESS WIRE--Intersect ENT, Inc. Nasdaq: XENT, a global ear, nose and throat ENT medical technology leader dedicated to transforming patient care, today announced the U.S. availability of the new Straight Delivery System SDS packaged with the companys PROPEL Mini mometasone furoate Sinus Implant. The combined packaging of the SDS with PROPEL Mini received premarket approval PMA by the U.S. Food and Drug Administration FDA which follows PMA for the 